Dr. Gury Doshi, M.D.

Clinical Trials

• A Study of Enzalutamide and LY3023414 in Men With Prostate Cancer

Media Releases

Get to know Hematologist-Oncologist Dr. Gury Doshi, who serves patients throughout the State of Texas.

Recognized as a fellowship-trained hematologist-oncologist, Dr. Doshi treats various cancers including breast cancer, lung cancer, colon cancer, as well as benign and malignant blood disorders, among others. She is the Medical Director of Oral Oncolytics at Texas Oncology, seeing patients at the offices in Bellville, Houston, and Katy, Texas.

Texas Oncology was founded in 1986 by a forward-thinking group of physicians who shared a vision to chart their own course. They believed there was a better way to provide cancer care. Together, they made community-based cancer treatment a reality. To date, the staff remains true to the practice’s core mission “to provide excellent, evidence-based care for each patient we serve, while advancing cancer care for tomorrow.”

Prior to joining Texas Oncology in 2010, Dr. Doshi served as an Assistant Professor in the Division of Oncology at The University of Texas at the Texas Medical Center. 

In her current capacity, she is the Associate Chair of the Genitourinary Committee of US Oncology Research. She joined the program in 2012 and has quickly risen as a leader, serving as the Principal Investigator for multiple studies and as a top enroller to clinical trials year after year. Her special interest is in the treatment of genitourinary tumors; prostate, kidney, and bladder cancers. She conducts clinical research trials at her Memorial City office. Her research publications include a review on sequencing therapies in metastatic renal cell carcinoma, and the use of morpho proteomic analysis to determine the selection of therapy in kidney cancer.

Back in 2000, Dr. Doshi obtained her medical degree from J.J.M Medical College in India. Upon relocating to the United States, she went on to serve her residency in internal medicine at Henry Ford Hospital in Detroit, Michigan. She then completed her fellowship at the Josephine Ford Cancer Center in Detroit, where she served as a Chief Fellow. 

Dedicated to her profession, the doctor is board-certified in hematology and medical oncology by the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

Among her professional affiliations, she is a member of the American Society of Clinical Oncology, the American Medical Association, and the Harris County Medical Society.

As a testament to her success, Dr. Doshi was named “Houston’s Top Doctors” by Houstonia Magazine (2013, 2014) and Physician Research Champion in the Gulf Coast Region by Texas Oncology. She was also awarded the “Rising Star” Award by the US Oncology Research, Annual Science Forum (2016).

Hematology is the branch of medicine concerned with the study of the cause, prognosis, treatment, and prevention of diseases related to blood. Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A hematologist-oncologist is a physician who specializes in the diagnosis, treatment, or prevention of blood diseases and cancers such as iron-deficiency anemia, hemophilia, sickle-cell disease, leukemia, and lymphoma. 

On a more personal note, Dr. Doshi is married and has two young children. She enjoys dancing, playing volleyball, and spending time with her kids. She is involved in improving cancer outreach locally.

In addition to English, she speaks Hindi, Punjabi, and Spanish.

Recommended Articles

• The Lymphoma Research Foundation's Light it Red for Lymphoma Night

  Lymphoma, a cancer of the lymphatic system, currently affects over 700,000 Americans who are living with or in remission from the disease. Statistics show that every seven minutes, someone in the United States is diagnosed with the condition, which amounts to approximately 80,000 people per year.The...

• New Diagnostic Tool Approved for Lymphoma

  A new diagnostic tool has been approved by the U.S. Food and Drug Administration (FDA) to help researchers identify leukemia and lymphoma cells by using a technique known as flow cytometry. A flow cytometry test for non-Hodgkin’s lymphoma (NHL) can help determine whether normal or abnormal DNA is...

• Teen with Hodgkin Lymphoma Skates with Her Hero, Mario Lemieux

  Lillian Tarasiewicz was diagnosed with stage 3B Hodgkin lymphoma in October of 2015. She currently resides in South Carolina, but because of her father’s Pennsylvania background, she grew up with a love for hockey and for the Pittsburgh Penguins. She always felt a special connection to Mario...

• Black Sabbath's Tony Iommi Discusses Struggles with Lymphoma

  Tony Iommi is one of the few rock and roll legends who can say that they fulfilled the industry’s cliché act of getting the band back together. In 2011, the loss of a good friend brought the Black Sabbath guitarist Iommi back into contact with the band’s original lead vocalist, Ozzy Osbourne....

• Touchdown For Lymphoma: Two Teams Put Rivalry Aside For a Cause

  Everyone knows that some rivalries can get pretty heated - especially when sports are involved. However, two football teams recognize that there is something more important - supporting a girl with Hodgkin's lymphoma. Although she was a cheerleader for the football team, they are now turning the...

• The Lymphoma Research Foundation Announces Partnership with the Annals of Lymphoma

  The Lymphoma Research Foundation (LRF) is the nation’s largest non-profit organization for lymphoma research, and they just announced their partnership with the Annals of Lymphoma (AOL). This was all revealed in September during Blood Cancer Awareness Month. LRF is devoted to exclusively funding...